NYSE - Nasdaq Real Time Price
USD
Novo Nordisk A/S (NVO)
39.00
+0.71
(+1.85%)
As of 11:37:53 AM EDT. Market Open.
Trade NVO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutNovo Nordisk faces intensifying competition after Eli Lilly reported strong third-quarter results and presented trial data favoring retatrutide over Ozempic 2 milligrams. Novo also has upcoming liver-disease data, a new pediatric insulin approval, and an ongoing share-repurchase program. The latest coverage presents a tension between competitive pressure and discounted valuation.
